Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer
Abstract Ovarian cancer (OvCa) is the sixth most common gynaecological cancer in the UK, accounting for over 200,000 deaths worldwide. Cancerous Inhibitor of Phosphatase 2 A (CIP2A) is an oncoprotein and an endogenous inhibitor of PP2A. CIP2A is a key regulator for cellular processes (e.g. prolifera...
Saved in:
| Main Authors: | Alice Filipe, Sayeh Saravi, Denis Mustafov, Suzana Panfilov, Simran Banger, Seyedehnajmeh Mousavikivaj, Maria Braoudaki, Senthilkumar Kailasam, Yasser Riazalhosseini, Michelle A. Sahai, Fotios Drenos, Cristina Sisu, Emmanouil Karteris |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-05013-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.
by: Anchit Khanna, et al.
Published: (2011-03-01) -
Identification of a New Lung Cancer Biomarker Signature Using Data Mining and Preliminary In Vitro Validation
by: Ferid Ben Ali, et al.
Published: (2025-06-01) -
CIP2A expression predicts recurrences of tamoxifen-treated breast cancer
by: Shawn Baldacchino, et al.
Published: (2017-10-01) -
New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
by: Denis Mustafov, et al.
Published: (2025-07-01) -
First‐line chemoimmunotherapy for patients with small‐cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis
by: Yu Li, et al.
Published: (2024-12-01)